CHP
NTGN

Cable Hill Partners’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Cable Hill Partners’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$1K – 811
2019
Q1 		$1K Hold
100
– – ﹤0.01% 811
2018
Q4 		$1K Sell
100
-1,400
-93% -$9.8K ﹤0.01% 777
2018
Q3 		$16K Buy
+1,500
New +$16.6K 0.01% 358

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Cable Hill Partners's NTGN Position: Q2 2019 in Review

Cable Hill Partners sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2019, closing a stake of 100 shares — an estimated $1K sold.

Cable Hill Partners first reported a position in NTGN in Q3 2018 and held it in 3 quarters. The position peaked at $16K in Q3 2018. 51 funds tracked by Wall St. Rank hold NTGN as of Q2 2019.

  • Cable Hill Partners reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Cable Hill Partners sold 100 Neon Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1K.
  • Cable Hill Partners first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2018 and held it in 3 quarters.
  • Cable Hill Partners's Neon Therapeutics, Inc. Common Stock position peaked at $16K in Q3 2018.
  • 51 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.